People and Business News — 6/21
The latest industry news of the past month, all in one place.
People News
Sharp has appointed Robert O’Beirn as Senior Vice President and Managing Director of its global Clinical Services business.
CROMSOURCE announced the appointment of Kris O’Brien as Global Head of TalentSource Life Sciences.
The IMA Group brought on Mike Minor as Executive Vice President of Clinical Research, and Debra Nichols as Senior Vice President of Commercial Affairs.
Clinical Ink announced the hiring of Janette Morgan as Executive Vice President, General Manager, EMEA.
Worldwide Clinical Trials, Inc. announced the promotion of Dave Bowser to Chief Operating Officer, and Sara Davis to Chief Commercial Officer.
Cytel Inc. has appointed Dr. Kyle Wathen as Vice President of Scientific Strategy and Innovation.
Signant Health announced the appointments of Jason Martin as Chief Operating Officer and Jean-Jacques Charhon as Chief Financial Officer.
Javara announced that it has appointed Brenda Reese as its first Chief Commercial Officer.
hyperCORE International chooses Seneca Harrison as their Internal Chief Diversity Officer.
Syneos Health announced the appointment of David S. Wilkes, MD, to the Company’s Board of Directors.
Business News
WCG IRB announced the launch of its 2021 International Fellows Program.
Yourway announced an expansion underway at its headquarters in Allentown, Pennsylvania, making the campus to over 300,000 square feet.
Recognition
Castor announced continued rapid adoption of its decentralized clinical trial platform to power COVID-19 studies globally.
OCT Clinical is among the top 3 CROs by the number of clinical trials launched in 2020, according to the Russian Registry of Clinical Trials.
Calyx announced that Calyx RIM has supported over 100 COVID-19 vaccine authorizations.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025
- IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
September 17th 2025
- Managing Background Therapies in the NIMBLE Phase III Trial
September 17th 2025
- Generative AI Transforms Clinical Study Report Development
September 16th 2025